news

The Department of Science and Technology Studies, UCL is an interdisciplinary centre for the integrated study of science's history, philosophy, sociology, communication and policy, located in the heart of London. Founded in 1921. Award winning for teaching and research, plus for our public engagement programme. Rated as outstanding by students at every level.

At UCL, the academic mission is paramount. Our ambition is to achieve the highest standards in our teaching and research.

Join us for BSc, MSc, and PhD study.

Staff books include:

Agar - Science and Spectacle
A A A
spacerspacer

UCL Donors help fund a forgotten treatment for TB

13 February 2014

Dr Friedrich Weleminsky

UCL donors John and Ann – Margaret Walton have made possible research to progress the understanding of tuberculomucin, a potential alternative treatment for TB that was invented before the Second World War.

The research taking place at the UCL Divisions of Infection and Immunity, and Medicine along with the UCL Department of Science & Technology Studies aims to explore the mode of action of tuberculomucin to assess its viability as an alternative treatment for TB. Dr Friedrich Weleminsky (pictured) developed it as a possible cure for TB in the early 20th Century. Historians and scientists will work together to understand the history of tuberculomucin as a TB treatment in the pre-antibiotic period and its possible application today.

Our research so far indicates that tuberculomucin had potential, but the start of the Second World War and discovery of antibiotics meant that the treatment was “lost”. In 2011, UCL was approached by Dr Weleminsky’s granddaughter, Dr Charlotte Jones, a retired GP who described her grandfather's treatment for TB. Today, certain strains of TB are now becoming resistant to the antibiotics we use to treat them, and alternative approaches need to be found urgently.

The generous gift from the Waltons will continue driving this project forward to identify new ways of treating TB, which after HIV/AIDS is the second largest single infectious agent in the world, affecting nearly 9 million people per year and killing more than 1 million.

‘Tuberculomucin – a forgotten treatment – may give us a powerful new method of combatting this ancient but continually burdensome disease which has always claimed more lives amongst the young and economically active than any other age group’ Dr Carole Reeves, UCL Department of Science and Technology Studies.

Using the information provided by Dr Charlotte Jones, the expertise of UCL academics and a very generous donation from John and Ann – Margaret Walton, UCL can now progress research into tuberculomucin and give TB patients hope for the future.

Image: Dr Friedrich Weleminsky courtesy of Dr Charlotte Jones.

Page last modified on 13 feb 14 09:25 by Jo E Pearson


UCL Department of Science and Technology Studies (STS)
0207 679 1328 office | +44 207 679 1328 international
sts@ucl.ac.uk | www.ucl.ac.uk/sts | @stsucl
postal address:  Gower Street, London, WC1E 6BT | United Kingdom
street address: 22 Gordon Square, London, WC1E 6BT | maps